McIlrath & Eck’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$19.5K Buy
454
+331
+269% +$14.2K ﹤0.01% 828
2025
Q4
$5.39K Buy
+123
New +$5.09K ﹤0.01% 763
2025
Q2
Sell
-1,420
Closed -$52.4K 948
2025
Q1
$52.4K Buy
+1,420
New +$50.6K 0.01% 303

Other funds holding EXEL

McIlrath & Eck's EXEL Position: Q1 2026 in Review

McIlrath & Eck increased its Exelixis (EXEL) stake by 269% in Q1 2026, buying an estimated $14.2K and bringing the position to 454 shares worth $19.5K. The position accounts for ﹤0.01% of the portfolio, ranked #828.

McIlrath & Eck first reported a position in EXEL in Q1 2025 and has held it in 3 quarters since. The position peaked at $52.4K in Q1 2025. 701 funds tracked by Wall St. Rank hold EXEL as of Q1 2026.

  • McIlrath & Eck held 454 shares of Exelixis worth $19.5K as of Q1 2026.
  • McIlrath & Eck bought 331 Exelixis shares in Q1 2026, an estimated $14.2K.
  • Exelixis made up ﹤0.01% of McIlrath & Eck's portfolio in Q1 2026, its #828 holding.
  • McIlrath & Eck first reported a position in Exelixis in Q1 2025 and has held it in 3 quarters since.
  • McIlrath & Eck's Exelixis position peaked at $52.4K in Q1 2025.
  • 701 funds tracked by Wall St. Rank held Exelixis as of Q1 2026.

Based on McIlrath & Eck's 13F filing for Q1 2026, filed 19 May 2026.